Fidelity Investments
REPL icon

Fidelity Investments’s Replimune Group REPL Stock Holding History

Fidelity Investments’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6M Sell
2,045,490
-936,090
-31% -$7.16M ﹤0.01% 1870
2025
Q4 		$29M Buy
2,981,580
+1,620,501
+119% +$13.8M ﹤0.01% 1646
2025
Q3 		$5.7M Buy
1,361,079
+969,419
+248% +$6.19M ﹤0.01% 2199
2025
Q2 		$3.64M Sell
391,660
-11,711
-3% -$102K ﹤0.01% 2280
2025
Q1 		$3.93M Buy
403,371
+56,089
+16% +$694K ﹤0.01% 2223
2024
Q4 		$4.21M Sell
347,282
-279,130
-45% -$3.39M ﹤0.01% 2216
2024
Q3 		$6.87M Sell
626,412
-120,776
-16% -$1.23M ﹤0.01% 2046
2024
Q2 		$6.72M Buy
747,188
+460,709
+161% +$3.21M ﹤0.01% 1990
2024
Q1 		$2.34M Sell
286,479
-539,382
-65% -$4.42M ﹤0.01% 2293
2023
Q4 		$6.96M Sell
825,861
-442,822
-35% -$5.13M ﹤0.01% 1962
2023
Q3 		$21.7M Sell
1,268,683
-275,885
-18% -$5.42M ﹤0.01% 1562
2023
Q2 		$35.9M Buy
1,544,568
+391,114
+34% +$7.64M ﹤0.01% 1392
2023
Q1 		$20.4M Sell
1,153,454
-226,980
-16% -$5.4M ﹤0.01% 1606
2022
Q4 		$37.5M Buy
1,380,434
+287,681
+26% +$5.98M ﹤0.01% 1364
2022
Q3 		$18.9M Buy
1,092,753
+2,543
+0.2% +$48.5K ﹤0.01% 1632
2022
Q2 		$19.1M Buy
1,090,210
+9,380
+0.9% +$154K ﹤0.01% 1669
2022
Q1 		$18.4M Buy
1,080,830
+26,711
+3% +$504K ﹤0.01% 1817
2021
Q4 		$28.6M Hold
1,054,119
– – ﹤0.01% 1655
2021
Q3 		$31.2M Hold
1,054,119
– – ﹤0.01% 1629
2021
Q2 		$40.5M Sell
1,054,119
-310,166
-23% -$10.6M ﹤0.01% 1542
2021
Q1 		$41.6M Sell
1,364,285
-1,262,132
-48% -$47.3M ﹤0.01% 1480
2020
Q4 		$100M Buy
2,626,417
+1,707,698
+186% +$71.2M 0.01% 1032
2020
Q3 		$21.1M Sell
918,719
-208,900
-19% -$4.76M ﹤0.01% 1540
2020
Q2 		$28M Buy
1,127,619
+237,859
+27% +$4.21M ﹤0.01% 1415
2020
Q1 		$8.87M Buy
889,760
+21,748
+3% +$324K ﹤0.01% 1726
2019
Q4 		$12.5M Buy
868,012
+440,000
+103% +$6.34M ﹤0.01% 1772
2019
Q3 		$5.95M Hold
428,012
– – ﹤0.01% 1997
2019
Q2 		$6.28M Sell
428,012
-46,402
-10% -$671K ﹤0.01% 2025
2019
Q1 		$7.22M Sell
474,414
-80
-0% -$997 ﹤0.01% 1972
2018
Q4 		$4.75M Sell
474,494
-8,290
-2% -$112K ﹤0.01% 2043
2018
Q3 		$7.77M Buy
+482,784
New +$8.46M ﹤0.01% 2008

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments's REPL Position: Q1 2026 in Review

Fidelity Investments reduced its Replimune Group (REPL) stake by 31% in Q1 2026, selling an estimated $7.16M and leaving 2,045,490 shares worth $15.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Fidelity Investments first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $100M in Q4 2020. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Fidelity Investments held 2,045,490 shares of Replimune Group worth $15.6M as of Q1 2026.
  • Fidelity Investments sold 936,090 Replimune Group shares in Q1 2026, an estimated $7.16M.
  • Replimune Group made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1870 holding.
  • Fidelity Investments first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Fidelity Investments's Replimune Group position peaked at $100M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.